Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
06-08 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
06-08 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
26 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-awarded-its-fourth-competitive-sbir-award-by-the-national-cancer-institute-bringing-total-sbir-funding-to-8-3-million-302412016.html
20 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-publication-of-seminal-paper-on-lns8801-in-cancer-research-communications-302406094.html
16 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-presentation-of-positive-clinical-data-of-lns8801-in-metastatic-melanoma-at-2024-esmo-annual-meeting-302249003.html
02 Apr 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-issuance-of-composition-of-matter-patent-for-lns8801-by-the-european-patent-office-302105941.html
06 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-announces-presentation-of-positive-clinical-data-of-lns8801-in-metastatic-uveal-melanoma-at-2023-asco-annual-meeting-301843582.html
19 Jan 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/linnaeus-therapeutics-granted-orphan-drug-designation-for-lns8801-for-the-treatment-of-patients-with-metastatic-cutaneous-melanoma-301725268.html
ABOUT THIS PAGE